Frederik Paulsen
Directeur Général chez Marussia Beverages BV
Provenance du réseau au premier degré de Frederik Paulsen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Marussia Beverages BV
 Marussia Beverages BV Food DistributorsDistribution Services Marussia Beverages BV is a Dutch company that sells beverages. The private company is based in Hoofddorp, NL. and has subsidiaries in United Kingdom, United States and Georgia. The company was founded in 2004 by Frederik Dag Arfst Paulsen. Frederik Dag Arfst Paulsen has been the CEO since 2004.
5
| Private Company | Food Distributors | 5 |
Mossburn Distillers Ltd.
 Mossburn Distillers Ltd. Beverages: AlcoholicConsumer Non-Durables Part of Marussia Beverages BV, Mossburn Distillers Ltd. is a British company that manufactures whisky and spirits. The company is based in Jedburgh, UK. Mossburn Distillers was founded in 2013.
3
| Subsidiary | Beverages: Alcoholic | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Frederik Paulsen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| SCHLUMBERGER AG | Beverages: Alcoholic | Director/Board Member | |
Sastre Holding S A
 Sastre Holding S A Financial ConglomeratesFinance Sastre Holding S A operates as a holding company. The company is headquartered in Zurich, Switzerland. | Financial Conglomerates | Director/Board Member | |
Bazell Pharma AG
 Bazell Pharma AG Medical/Nursing ServicesHealth Services Part of Amzell Ltd., Bazell Pharma AG is a clinical development and research and development laboratory facility. The company is based in Allschwil, Switzerland. Bazell Pharma was acquired by Amzell Ltd. on March 25, 2021. | Medical/Nursing Services | Director/Board Member | |
Amzell Ltd.
 Amzell Ltd. Pharmaceuticals: MajorHealth Technology Amzell Ltd. is a Dutch virtual development pharmaceutical company that specializes in taking candidate or repurposed drugs and devices through to proof of concept or registration for sale to commercial healthcare companies. The private company is based in Hoofddorp, Netherlands, and has subsidiaries in Switzerland. The company focuses on developing well-characterized active substances using innovative platform drug delivery technologies to provide more effective drug delivery, increased efficacy, and improved safety and compliance. One of their products, AMZ001, is a non-invasive topical gel formulation containing 3.06%% diclofenac sodium, which is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain related to knee osteoarthritis. The CEO of the company is Dario N. R. Carrara. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Suisse | 3 |
| Autriche | 2 |
| Pays-Bas | 2 |
Sectorielle
| Consumer Non-Durables | 2 |
| Finance | 2 |
| Health Services | 2 |
| Health Technology | 2 |
Opérationnelle
| Director/Board Member | 10 |
| Corporate Secretary | 1 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Frederik Paulsen
- Connexions Sociétés
